AUA Updates Kidney Stone Management Guidelines with Expanded Evidence-Based Recommendations
Event summary
- The American Urological Association (AUA) released its 2026 Medical Management of Kidney Stones Guideline on July 30, 2026.
- The guideline includes 39 evidence-based recommendations for diagnosing, treating, preventing, and monitoring kidney stones in adults and children.
- Key topics cover dietary modifications, pharmacologic therapies, and long-term patient monitoring to reduce recurrence.
- Co-chairs Brian R. Matlaga, MD, MPH, and Margaret S. Pearle, MD, PhD, FRCS, emphasized tailored strategies for diverse populations.
The big picture
Kidney stones are a prevalent condition with significant healthcare costs, making evidence-based guidelines critical for optimizing patient outcomes. The AUA's updated recommendations reflect advancements in understanding stone disease and align with broader trends toward personalized medicine and preventive care in urology. With over 25,000 members globally, the AUA's influence extends across clinical practice, research, and health policy.
What we're watching
- Adoption Pace
- How quickly clinicians integrate these guidelines into practice, particularly for pediatric patients.
- Outcome Impact
- Whether the emphasis on prevention and long-term management reduces recurrence rates and emergency department visits.
- Pharmacologic Advances
- The pace at which targeted pharmacologic therapies evolve alongside dietary strategies in kidney stone management.